OC
RXII

Oppenheimer & Co’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Oppenheimer & Co’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-29,600
Closed -$11K – 1393
2016
Q3 		$11K Sell
29,600
-48,000
-62% -$17.8K ﹤0.01% 1263
2016
Q2 		$36K Buy
77,600
+3,300
+4% +$1.53K ﹤0.01% 1197
2016
Q1 		$101K Sell
74,300
-20,000
-21% -$27.2K ﹤0.01% 1182
2015
Q4 		$138K Buy
94,300
+2,400
+3% +$3.51K ﹤0.01% 1181
2015
Q3 		$145K Sell
91,900
-45,000
-33% -$71K ﹤0.01% 1223
2015
Q2 		$233K Buy
136,900
+8,800
+7% +$15K 0.01% 1212
2015
Q1 		$178K Sell
128,100
-33,700
-21% -$46.8K ﹤0.01% 1338
2014
Q4 		$244K Sell
161,800
-44,500
-22% -$67.1K 0.01% 1118
2014
Q3 		$425K Buy
206,300
+26,601
+15% +$54.8K 0.01% 918
2014
Q2 		$549K Buy
179,699
+103,000
+134% +$315K 0.02% 824
2014
Q1 		$192K Sell
76,699
-8,101
-10% -$20.3K 0.01% 1255
2013
Q4 		$421K Buy
84,800
+55,800
+192% +$277K 0.01% 881
2013
Q3 		$66K Buy
+29,000
New +$66K ﹤0.01% 1270

Oppenheimer & Co's RXII Position: Q4 2016 in Review

Oppenheimer & Co sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 29,600 shares — an estimated $11K sold.

Oppenheimer & Co first reported a position in RXII in Q3 2013 and held it in 13 quarters. The position peaked at $549K in Q2 2014. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

  • Oppenheimer & Co reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
  • Oppenheimer & Co sold 29,600 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $11K.
  • Oppenheimer & Co first reported a position in GALENA BIOPHARMA INC COM in Q3 2013 and held it in 13 quarters.
  • Oppenheimer & Co's GALENA BIOPHARMA INC COM position peaked at $549K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Oppenheimer & Co's 13F filing for Q4 2016, filed 2 Feb 2017.